Showing 11-20 of 321 results for "".
ILUMYA SUPPORT™ patient access for commercial and Medicare Part B patients
https://practicaldermatology.com/topics/psoriasis/ilumya-support-patient-access-for-commercial-and-medicare-part-b-patients/19860/ILUMYA SUPPORT™ offers comprehensive programs and services to help patients start and stay on therapy with ILUMYA™. Learn about the three main patient access programs offered by ILUMYA SUPPORT™: the Early Access Program, the Co-pay Program, and the Patient Assistance Program. ILUMYA™ is reimbursed uSocial Media as a Force for Good: How to Think Like a B Corp
https://practicaldermatology.com/topics/practice-management/social-media-as-a-force-for-good-how-to-think-like-a-b-corp/24009/For dermatologists, social media networks are underutilized when marketing their practices—create quality and trusted material, deliver practice-specific messaging strategies, and convey and sustain reliable information.Taylor Made: One-of-a-kind Solutions for Device-based Services
https://practicaldermatology.com/topics/practice-management/taylor-made-one-of-a-kind-solutions-for-device-based-services/18789/An expert on the leading edge of device-based interventions, Mark B. Taylor, MD has learned when and how to adopt technologies and how to get the most from the systems in his practice. In this edition of Best Practices in Aesthetics, host Joel L. Cohen, MD asks Dr. Taylor to share his tips for optimDiagnosis: “Brochure-itis”
https://practicaldermatology.com/topics/practice-management/diagnosis-brochure-itis/21604/You can make over practice websites with simple edits.Finding Meaning in a Complicated EHR Picture
https://practicaldermatology.com/topics/practice-management/finding-meaning-in-a-complicated-ehr-picture/21302/Introducing the next edition of the EHR User series, featuring perspective on individual systems and the broader HIT picture.Allergan Strikes $66 Billion Deal with Actavis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-allergan-strikes-66-billion-deal-with-actavis/19021/In this edition of DermWireTV, host Ranna Jaraha discusses this week's blockbuster merger deal between Allergan and Actavis. Also featured in this edition is a new report detailing the rising costs of treating skin cancer, and high recognition for a dermatologic device manufacturer.DermwireTV — Nestle acquires Galderma; Dermatologic procedures surge
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-nestle-acquires-galderma-dermatologic-procedures-surge/19157/In this edition of DermWireTV, from the publishers of Practical Dermatology® magazine: Nestle acquires Galderma, dermatologic procedures surge, and we look ahead to the annual meeting in Denver. #DermWireTo Be Shorr: Negotiate with Confidence
https://practicaldermatology.com/topics/practice-management/to-be-shorr-negotiate-with-confidence/18717/Knowing when and how to negotiate is key. Sometimes, the best outcome is possible when a third party negotiates on your behalf. Jay Shorr explains in this edition of To Be Shorr.Merz Acquires Ulthera; Ulthera Gets Decolletage Indication, and a New Topical for Onychomycosis
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-merz-acquires-ulthera-ulthera-gets-decolletage-indication-and-a-new-topical-for-onychomycosis/19117/In this edition of DermWireTV, from the publishers of Practical Dermatology® magazine, learn the latest on the Merz/Ulthera acquisition, a new topical for toenail fungus, and FDA accepts Kythera's NDA.Top Stories of 2014 and the Aesthetic Pipeline
https://practicaldermatology.com/topics/psoriasis/top-stories-of-2014-and-the-aesthetic-pipeline/18996/In this special edition of DermWireTV we take a look back at some of the biggest stories of 2014. Plus experts weigh in on the future of aesthetic medicine.